| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.60▼ | 8.58▲ | 8.58▲ | 8.43▲ | 5.14▲ |
| MA10 | 8.58▲ | 8.62▼ | 8.61▼ | 8.20▲ | 2.85▲ |
| MA20 | 8.60▼ | 8.56▲ | 8.61▼ | 5.42▲ | 1.77▲ |
| MA50 | 8.60▼ | 8.32▲ | 8.16▲ | 2.51▲ | 1.16▲ |
| MA100 | 8.20▲ | 6.73▲ | 5.33▲ | 1.61▲ | 1.05▲ |
| MA200 | 6.08▲ | 3.64▲ | 2.94▲ | 1.17▲ | 1.66▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.031▼ | -0.056▼ | 0.147▲ | 0.912▲ |
| RSI | 50.525▲ | 53.376▲ | 55.745▲ | 86.139▲ | 96.795▲ |
| STOCH | 54.777 | 34.158 | 45.423 | 67.722 | 53.182 |
| WILL %R | -43.750 | -62.500 | -42.553 | -8.799▲ | -8.761▲ |
| CCI | -1.010 | -7.783 | 21.991 | 67.233 | 163.737▲ |
| CDL | $XLO Shooting Star Candlestick Pattern Detected | Set Alert |
|
Tuesday, March 31, 2026 01:58 PM
XTX501, a potential best-in-class bispecific PD-1 / masked IL-2, on track for planned IND submission in mid-2026 and Phase 1 initiation in the second half of 2026 Advancing potential first-in-class ...
|
|
Saturday, March 28, 2026 06:29 PM
Detailed price information for Xilio Therapeutics Inc (XLO-Q) from The Globe and Mail including charting and trades.
|
|
Saturday, March 28, 2026 05:16 PM
Detailed price information for Xilio Therapeutics Inc (XLO-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/04/26 | 8.54 | 8.795 | 8.4601 | 8.48 | 45,647 |
| 31/03/26 | 8.33 | 8.88 | 8.33 | 8.41 | 72,220 |
| 30/03/26 | 8.48 | 8.5106 | 8.0201 | 8.235 | 13,167 |
| 27/03/26 | 8.57 | 8.79 | 8.30 | 8.32 | 25,038 |
| 26/03/26 | 8.62 | 9.2499 | 8.41 | 8.68 | 58,833 |
| 25/03/26 | 8.29 | 8.6299 | 8.28 | 8.53 | 44,619 |
| 24/03/26 | 7.86 | 8.6445 | 7.86 | 8.37 | 73,091 |
| 23/03/26 | 7.99 | 8.1099 | 7.75 | 7.86 | 39,797 |
| 20/03/26 | 7.25 | 7.99 | 7.16 | 7.86 | 107,400 |
| 19/03/26 | 7.49 | 7.7799 | 7.2025 | 7.29 | 51,449 |
|
|
||||
|
|
||||
|
|